“Hospira is the world’s leading provider of injectable drugs and infusion technologies. Through its broad integrated portfolio, Hospira is uniquely positioned to Advanced Wellness by improving patient and caregiver safety while reducing healthcare costs.” Hospira has 70 years of hospital backing. Although Hospira has been in the works since 1936 Hospira actually became an individual company and started trading on the Stock Market in May of 2004, it is a spin-off company of Abbott Laboratories. The company was founded by Dr. Wallace C. Abbott in his kitchen in the 1880’s. Dr. Abbott was also the founder of Abbott Laboratories which is where tests, trials and development took place for the next couple decades for Hospira. Today F. Michael Ball is the CEO of Hospira, he has been in the healthcare industry for over 25 years and with Hospira since March 2011. Previously he held several positions at Allergan, he was employed there 16 years. He also worked at Syntex